Proteona to develop antibody treatment for
COVID-19 to help blood cancer patient at risk of infection.
Read more about our response to the global outbreak on
Proteona received Seal of Excellence
from Horizon 2020, European Commission.
The Seal of Excellence is a quality label certifying top
innovation ideas worthy of investment.
Meet Proteona at the 38th Annual J.P. Morgan Healthcare
Conference in San Francisco, USA.
We are excited to be there to discuss the impact of single
cell multi-omics on the future of precision medicine. See you there!
Single cell multi-Omics selected as Method of the Year 2019
by Nature Methods.
It specially recognizes the recent technology development
where multiple types of measurement can simultaneous be made.
Meet Proteona at the 1st Advanced Therapies Science Meeting, RESTORE,
in Berlin, Germany.
The 1ATSM meeting is part of the RESTORE initiative in Europe.
Proteona is a proud supporter of RESTORE.
Proteona co-founder publishes novel AI method for single
cell data annotation.
Dr Shawn Hoon, a scientific co-founder of Proteona, has
published a novel AI method named "MapCell" for single
cell data annotation.
Meet Proteona at the “LifeTime meets industry” conference
in Basel, Switzerland.
The LifeTime Initiative aims to understand the underlying
mechanisms of key diseases on a cellular and molecular level. Proteona is a proud supporter of LifeTime.
Meet Proteona at the BioRN Lounge event in Heidelberg,
Dr Andreas Schmidt, the CEO of Proteona Pte. Ltd., will
be presenting at the BioRN Lounge event, taking place at 7pm
on the 29th of October at Urban Kitchen, Heidelberg.
Meet Proteona at the AVCO Annual Conference 2019 in Vienna,
Dr Andreas Schmidt will speak in the panel “Investing in
Healthcare Opportunities in Europe” at 17:10pm. AVCO is Austria’s
leading event for investors and entrepreneurs.
Proteona Selected Among Top 20 Startups for MedTech Innovator
Asia Pacific Showcase.
Proteona will present its ESCAPE™ single cell proteogenomic
analysis technology and how it can make a difference for advancing
Meet Proteona at the European Business Development Conference
in Heidelberg, Germany.
Dr Schmidt will speak about how Proteona helps to address
the unmet clinical need in immuno-oncology using single cell
Meet the Proteona Team in Nanjing, China.
The Proteona team will be presenting two scientific talks
in Nanjing in June 2019 on the importance of single-cell proteogenomic
analysis for cell therapies.
Meet the Proteona team at the CAR-TCR Sumit Asia in Shanghai,
The team will share about the new ESCAPE CAR T platform
for comprehensive characterization of CAR T immunotherapeutics,
which can be integrated into all stages of the therapy.
Proteona Co-founder Gene Yeo Wins 2019 Xconomy Award San
Diego for Big Ideas.
Prof. Yeo is a Professor of Cellular and Molecular
Medicine in the University of California San Diago, and a visiting
professor at the National University of Singapore.
Meet the Proteona team at the 9th Mildred Scheel Cancer
Conference in Bonn, Germany.
Dr Schmidt will discuss how single cell analysis using Proteona’s
ESCAPE platform can help advancing novel immunotherapies and
understanding patient response.
Meet the Proteona team at the Phar-East Conference in Singapore.
Dr Andreas Schmidt, Proteona Chief Executive Officer, will
share on the latest updates on Proteona at 14:40pm and will
be available during the conference for discussions.
Meet the Proteona team at the Single Cells: Technology to
Biology Symposium in Singapore.
Dr Scolnick will give a talk titled "Escape RNA sequencing: Simultaneous
single-cell protein, gene expression and mutation analysis to profile
Meet the Proteona team at the Labiotech REFRESH event in
Dr Schmidt will be available during the event to discuss
their ESCAPE™ RNA Sequencing technology single cells proteogenomic analysis.
Meet the Proteona team at the 11th AFOB Regional Symposium
(ARS) conference in Singapore.
Dr Scolnick will present on Proteona's recent
development on combining protein and gene expression to investigate
the cell therapy manufacture.
Meet the Proteona team at the 37th Annual J.P. Morgan HEALTHCARE
CONFERENCE in San Francisco.
Dr Schmidt will discuss their ESCAPE™ RNAseq technology for
obtaining protein and gene expression information from the same